Viracor-IBT Laboratories’ Acquisition of the National Institute of Transplantation Enhances Testing Services for Transplant Patients

Combined diagnostic expertise will help more U.S. transplant patients
Lee’s Summit, MO – December 10, 2013 –
Viracor-IBT Laboratories, Inc. announced today it has closed on its previously announced transaction to purchase assets associated with the laboratory operations of the National Institute of Transplantation (NIT), a non-profit organization committed to advancing the science and practice of transplantation. NIT made the decision to transfer its laboratory operations to Viracor-IBT to perpetuate the mission of its foundation, build on the legacy of its laboratory operations, and to provide testing services to more transplant patients across the U.S.

Press-Release_Viracor-IBT-and-NIT-Closing_12.6.13.pdf download View | Download
Categories: MNITF Press